McGuireWoods recently advised clients in four capital markets transactions that provided funding for innovative healthcare and life sciences companies.
The firm represented Titan Partners Group, a division of American Capital Partners, as sole bookrunner in a $22.4 million IPO by Actuate Therapeutics, Inc., a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult to treat cancers. The deal closed Aug. 14, 2024. The McGuireWoods team included partner Stephen Older, counsel Andrew Terjesen and Felix Saratovsky, and associate Latasha James.
McGuireWoods also represented Titan Partners Group as sole bookrunner in an $11 million public offering of common stock and pre-funded warrants by Gain Therapeutics, a clinical-stage biotech company leading the discovery and development of next generation allosteric therapies. The transaction closed June 17, 2024. Older and partner Carly Ginley led the McGuireWoods team representing Titan Partners Group, with support from Terjesen and associate Dana Aboud.
McGuireWoods advised Newbridge Securities Corp. as exclusive placement agent in a $3.4 million registered direct offering of ordinary shares and pre-funded warrants by Inspira Technologies Oxy B.H.N. Ltd., an innovative medical technology company in the life support arena. The transaction closed June 18, 2024. The firm’s deal team included Older, Terjesen and Aboud.
In addition, the firm represented Brookline Capital Markets as exclusive placement agent in a $3 million private placement of common stock by Carmell Corp., a bio-aesthetics company focused on skin and hair health. The deal closed on April 4, 2024. Older, Saratovsky and associate Preston Williams represented Brookline Capital Partners.
McGuireWoods’ capital markets team has earned global recognition for its representation of corporate issuers and underwriters in complex corporate and securities matters, repeatedly ranking among the top law firms for debt and equity issuances in authoritative league tables.
“We were pleased to help our clients execute these transactions and achieve their business objectives,” Older said. “These deals are a testament to the depth, talent and versatility of McGuireWoods’ securities and capital markets team.”
Original source can be found here.